# A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.

> **NCT00493155** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 48 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** RG1530

## Key facts

- **NCT ID:** NCT00493155
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00493155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00493155, "A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00493155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*